Status:
COMPLETED
ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction
Lead Sponsor:
Queen's University
Conditions:
Erectile Dysfunction
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Androgen deficiency in the aging male is poorly understood. The objective of this study will be to determine the role of testosterone and DHEA in enhancing sexual interest and sexual performance.
Detailed Description
120 men with a diagnosis of Erectile dysfunction (ED) will be randomized to one of three arms in the study, DHEA (50 mg), testosterone \[T\] (80 mg) or placebo. Patients will be evaluated after starti...
Eligibility Criteria
Inclusion
- Erectile dysfunction (ED)
Exclusion
- Prior use of DHEA or T
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00202163
Start Date
December 1 2006
End Date
September 1 2007
Last Update
January 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Advanced Urological Research
Kingston, Ontario, Canada, K7L 3N6